OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
45
Results
Show all
Save search
Copy query
Show results for
Unknown
(45)
Publication Date
Release Date
2021
(9)
2025
(7)
2022
(7)
2023
(6)
2020
(5)
2024
(3)
2019
(2)
2013
(2)
2018
(1)
2017
(1)
2015
(1)
2011
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
The Immunological Profile of SARS-CoV-2 Infection in Children Is Linked to Clinical Severity and Age.
Not available
S-EPMC10095251
|
biostudies-literature
Cite
The core cysteines, (C909) of islet antigen-2 and (C945) of islet antigen-2β, are crucial to autoantibody binding in type 1 diabetes.
Not available
S-EPMC3526053
|
biostudies-literature
Cite
Diabetes Antibody Standardization Program: First evaluation of assays for autoantibodies to IA-2β.
Not available
S-EPMC3198291
|
biostudies-literature
Cite
A/H1N1 hemagglutinin antibodies show comparable affinity in vaccine-related Narcolepsy type 1 and control and are unlikely to contribute to pathogenesis.
Not available
S-EPMC7893011
|
biostudies-literature
Cite
A public health antibody screening indicates a marked increase of SARS-CoV-2 exposure rate in children during the second wave.
Not available
S-EPMC8018829
|
biostudies-literature
Cite
Dysglycemia after COVID-19 pneumonia: a six-month cohort study.
Not available
S-EPMC8177035
|
biostudies-literature
Cite
Universal screening for early detection of chronic autoimmune, metabolic and cardiovascular diseases in the general population using capillary blood (UNISCREEN): low-risk interventional, single-centre, pilot study protocol
Not available
S-EPMC10916121
|
biostudies-literature
Cite
Islet Autoantibody Standardization Program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops.
Not available
S-EPMC10036445
|
biostudies-literature
Cite
Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12.
Not available
S-EPMC6445455
|
biostudies-literature
Cite
Post hoc
analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of responders.
Not available
S-EPMC10319139
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets